| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/07/1998 | CN1169734A Method for purifying keratinocyte growth factors |
| 01/07/1998 | CN1169729A Modulators functions of FAS/APOL receptors |
| 01/07/1998 | CN1036934C Process for preparing isohirudins with improved stability |
| 01/06/1998 | US5705625 Genetic engineering; medical diagnosis |
| 01/06/1998 | US5705617 Neurotrophic factors having altered receptor binding specificities |
| 01/06/1998 | US5705616 Proteins from yeast host strains with defects in N-glycosylation |
| 01/06/1998 | US5705611 Human GM-CSF receptor component |
| 01/06/1998 | US5705608 Polypeptides with dna sequence codes |
| 01/06/1998 | US5705606 Polypeptides for binding aggregation mediators such as fibrogen |
| 01/06/1998 | US5705484 Biologically active polypeptide fusion dimers |
| 01/06/1998 | US5705387 Heat-inducible N-degron module |
| 01/06/1998 | US5705377 Tyrosine kinase |
| 01/06/1998 | US5705376 Gene encoding carboxypeptidase of Aspergillus niger |
| 01/06/1998 | US5705364 Mammalian cell culture process |
| 01/06/1998 | US5705361 Hybrid transposon with PT operon, plasmids and bacterial strains therefor |
| 01/06/1998 | US5705360 Chemokine N-terminal deletion mutations |
| 01/06/1998 | US5705341 MDC proteins and DNAs encoding the same |
| 01/06/1998 | US5705163 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
| 01/06/1998 | US5705159 Immunoreactive peptide sequence from a 43 KD human cancer antigen |
| 01/06/1998 | US5705158 Kits with antileukocyte antibody conjugates |
| 01/06/1998 | US5705156 Pseudomonas exotoxins binding to cells |
| 01/06/1998 | US5705150 Antigen specific plasmacytomas and antibodies derived therefrom |
| 01/06/1998 | CA2108897C Genome coding phytolacca antiviral protein and a recombinant expression vector therefor |
| 12/31/1997 | WO1997049832A2 Method of identifying cytochrome p450 |
| 12/31/1997 | WO1997049819A1 Novel amino-terminal deblocking enzyme |
| 12/31/1997 | WO1997049818A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 12/31/1997 | WO1997049815A1 Retinoid metabolizing protein |
| 12/31/1997 | WO1997049812A2 Process for extracting and purifying recombinant, non-lipidised osp-protein |
| 12/31/1997 | WO1997049809A1 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 12/31/1997 | WO1997049805A2 Recognition molecules interacting specifically with the active site or cleft of a target molecule |
| 12/31/1997 | WO1997049794A1 Method for protein stabilisation of wines |
| 12/31/1997 | WO1997049727A1 Aatt promoter element and transcription factor |
| 12/31/1997 | WO1997049725A1 Modified factor viii |
| 12/31/1997 | WO1997049428A1 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 12/31/1997 | WO1997049426A1 Remedies for acute pulmonary injuries due to indirect causes containing anti-il-8 antibody as the active ingredient |
| 12/31/1997 | WO1997049424A1 Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same |
| 12/31/1997 | WO1997044000A3 Dna-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
| 12/31/1997 | WO1997030159A3 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 12/31/1997 | CN1169158A Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 12/31/1997 | CA2261029A1 Aatt promoter element and transcription factor |
| 12/31/1997 | CA2259636A1 Process for extracting and purifying recombinant, non-lipidised osp-protein |
| 12/31/1997 | CA2257180A1 Method of identifying cytochrome p450 |
| 12/31/1997 | CA2254782A1 Remedies for acute pulmonary injuries due to indirect causes containing anti-il-8 antibody as the active ingredient |
| 12/30/1997 | US5703213 Monoclonal antibodies which recognize an adenocarcinoma cell antigen |
| 12/30/1997 | US5703212 Preventive for circulatory diseases |
| 12/30/1997 | US5703209 Purified and isolated polypeptide encoded by nucleic acid sequence of nucleic acid molecule which is fragment of gene encoding amyloid precursor protein isoform |
| 12/30/1997 | US5703207 Protein active in humoral hypercalcemia of malignancy-PTHrP |
| 12/30/1997 | US5703039 Chimeric toxins |
| 12/30/1997 | US5703038 Emhanced biological activity |
| 12/30/1997 | US5702946 Interleukins |
| 12/30/1997 | US5702936 Polypeptides |
| 12/30/1997 | US5702934 Processes for producing an enzyme |
| 12/30/1997 | US5702923 Active against bacteria and effective at ph between 2 and 8 |
| 12/30/1997 | US5702921 Expression of biologically active human C-reactive protein in escherichia coli |
| 12/30/1997 | US5702920 Polypeptides |
| 12/30/1997 | US5702917 Polynucleotides encoding human ICAM-4 |
| 12/30/1997 | US5702910 Using two kinds of monoclonal antibodies; complexing |
| 12/30/1997 | US5702907 Nucleotide sequence |
| 12/30/1997 | US5702905 Specificity, sensitivity; diagnosis of cardiac muscle damage |
| 12/30/1997 | US5702904 Immunoassay for identifying alcoholics and monitoring alcohol consumption |
| 12/30/1997 | US5702705 Antibody methods for the treatment of a hormone-mediated disease |
| 12/30/1997 | US5702698 Promoting production of colony stimulating factor |
| 12/30/1997 | CA2133850C Process for preparing virus-resistant transgenic plant |
| 12/30/1997 | CA1339607C Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients |
| 12/30/1997 | CA1339606C Polypeptides complementary to peptides or proteins having an amino acid sequence or necleotide coding sequence at least partially known |
| 12/29/1997 | EP0814160A2 KEX2 proteinase inhibitor |
| 12/29/1997 | EP0814159A2 Transgenic non-human animals capable of producing heterologous antibodies |
| 12/29/1997 | EP0814154A2 Recombinant alphavirus vectors |
| 12/29/1997 | EP0814089A2 Respiratory syncytial virus: vaccines and diagnostic assays |
| 12/29/1997 | EP0813604A1 Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand |
| 12/29/1997 | EP0813545A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
| 12/29/1997 | EP0813541A1 Process for producing a protein |
| 12/29/1997 | EP0813423A1 Composition to ameliorate osteolysis and metastasis |
| 12/29/1997 | EP0813419A1 Modulators of regulatory proteins |
| 12/29/1997 | EP0813364A1 Bacillus thuringiensis isolates active against weevils |
| 12/29/1997 | EP0672141A4 Methods of preparing soluble, oligomeric proteins. |
| 12/29/1997 | EP0632727B1 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 12/29/1997 | EP0552296B1 Mouse monoclonal antibodies |
| 12/29/1997 | EP0546096B1 Macrophage activating factor from vitamin d binding protein |
| 12/24/1997 | WO1997048983A1 SCREENING COMPOUNDS FOR THE ABILITY TO ALTER THE PRODUCTION OF AMYLOID-β PEPTIDE (x-≥41) |
| 12/24/1997 | WO1997048808A1 Bacterial production of interferon-beta using low levels of sodium and potassium ions |
| 12/24/1997 | WO1997048807A1 CHEMOKINE β-15 |
| 12/24/1997 | WO1997048804A2 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
| 12/24/1997 | WO1997048802A1 HUMAN cAMP-DEPENDENT PROTEIN KINASE INHIBITOR HOMOLOG |
| 12/24/1997 | WO1997048801A2 Polynucleotides encoding secreted proteins |
| 12/24/1997 | WO1997048800A1 Polynucleotides encoding secreted proteins from human pbmc |
| 12/24/1997 | WO1997048799A2 Polynucleotides from human fetal brain encoding secreted proteins |
| 12/24/1997 | WO1997048797A1 Novel human chromosome 16 genes, compositions, methods of making and using same |
| 12/24/1997 | WO1997048794A1 Amidase |
| 12/24/1997 | WO1997048727A1 New fibrinogen binding protein originating from coagulase-negative staphylococcus |
| 12/24/1997 | WO1997048724A2 Human metabotropic glutamate receptor |
| 12/24/1997 | WO1997048721A1 Hodgkin's disease associated molecules and uses thereof |
| 12/24/1997 | WO1997048418A1 Improved method for treatment and diagnosis of il-5 mediated disorders |
| 12/24/1997 | WO1997048408A2 Method for the prevention and treatment of mastitis |
| 12/24/1997 | WO1997048370A2 Vaccines comprising synthetic genes |
| 12/24/1997 | WO1997043314A3 Collagen binding protein compositions and methods of use |
| 12/24/1997 | WO1997041230A3 Cc-type chemokines |
| 12/24/1997 | WO1997040073A3 Biologically active protein (collagen fragment hf-coll-18/514cf) for inhibiting the growth of tumours and capillary profilerations |
| 12/24/1997 | CN1168699A Protein kinase NPK-llo |
| 12/24/1997 | CN1168698A Recombinant proteins of a Pakistani Strain of Hepatitis E and their use in diagnostic methods and vaccines |